Jaksil, Kadil .
HRN: 14-09-14 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/28/2023
METRONIDAZOLE 125MG/5ML, 60ML (BOT)
01/28/2023
02/04/2023
PO
6 Ml
TID
Amoebiasis
Waiting Final Action
Indication: Empiric Then Culture-directed Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes